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Methicillin-resistant Staphylococcus aureus (MRSA) are resistant to b-lactam antibiotics, which inhibit bac-
terial cell wall synthesis. In this issue ofCell Host &Microbe, Mu¨ller et al. (2015) show that b-lactam treatment
of MRSA leads to synthesis of an altered cell wall that increases inflammasome activation and immunopa-
thology during skin infection.Staphylococcus aureus is both a human
commensal that persistently or intermit-
tently colonizes the skin andnasalmucosa
of a significant proportion of the human
population, and a leading human path-
ogen that can cause infections at a variety
of superficial and invasive body sites.
A master of adaptation, S. aureus has
evolved strain-specific virulence factors
and has acquired resistance to amultitude
of antibiotics, including widely used b-lac-
tam antibiotics such as methicillin. His-
torically, methicillin-resistant S. aureus
(MRSA) strains were predominantly ac-
quired in hospitals; however, in the last
20 years MRSA strains have become a
prevalent cause of infection in otherwise
healthy individuals in the community.
MRSA are resistant to b-lactam antibi-
otics, which are substrate analogs of the
essential bacterial penicillin-binding pro-
teins (PBPs). PBPs play a pivotal role dur-
ing synthesis of the bacterial cell wall,
crosslinking peptides between the glycan
chains that form the skeleton core of the
peptidoglycan (PGN) cell wall. The mecA
gene of MRSA encodes an alternative
PBP,PBP2a.PBP2a is inducedandbound
by b-lactam antibiotics but evades their
inhibitory action via a distorted active site
that inhibits conformational changes
required for acylation-induced inactivation
(Lim and Strynadka, 2002). During antibi-
otic-mediated inhibition of other PBPs,
MRSA depends exclusively on the b-lac-
tam-resistant PBP2a, although the result-
ing cell wall is not as heavily crosslinked
(SnowdenandPerkins, 1991). In this issue,
Liu andcolleagues (Mu¨ller et al., 2015) pre-
sent intriguing data showing that the
poorly crosslinked PGN that results from
exposure of MRSA to b-lactam antibiotics520 Cell Host & Microbe 18, November 11, 20induces a hyperinflammatory response in
human and murine macrophages charac-
terized by increased IL-1b production
(Figure 1). Similar effects were seen
with mecA-expressing Staphylococcus
epidermidis and with methicillin-sensitive
S. aureus exposed to sublethal doses of
b-lactam antibiotics.
IL-1b is critical for immunity to
S. aureus. Its antistaphylococcal role has
been best studied in models of skin infec-
tion, where it triggers the influx of neutro-
phils, which are essential for abscess
formation and bacterial clearance (Miller
et al., 2007). Production of active IL-1b
in macrophages is dependent on two sig-
nals: (1) the sensing of an extracellular
threat, classically perceived by Toll-like
receptors (TLRs), that initiates transcrip-
tion and translation of a precursor pro-
IL-1b protein, and (2) the detection of an
intracellular danger signal by cytosolic re-
ceptors, such as the Nod-like receptors
(NLRs), that mediate the assembly of
multi-protein complexes called inflamma-
somes, which ultimately trigger cleavage
of pro-IL-1b into its active form via the
cysteine protease caspase-1 (Martinon
et al., 2009).
In the current study, Liu and colleagues
advance their previous observation that
reversing the intrinsic resistance of the
S. aureus cell wall to lysozyme, a host
enzyme that hydrolyses the glycan back-
bone of PGN, increases inflammasome
activation and IL-1b release (Shimada
et al., 2010). This earlier study was an indi-
cation that a structurally sound cell wall
helps S. aureus dampen inflammatory re-
sponses. Now, the authors find that the
induction ofmecA expression after expo-
sure of MRSA to b-lactam antibiotics trig-15 ª2015 Elsevier Inc.gers PBP2a-mediated synthesis of a
structurally altered cell wall containing
poorly crosslinked PGN, which in turn
induces significantly higher levels of
secreted IL-1b than the conventional cell
wall (Figure 1). These results were recapit-
ulated using enzymatically digested PGN,
or by using MRSA mutants with altered
levels of peptide crosslinking of the cell
wall. Phagocytic uptake of the poorly
crosslinked PGN from antibiotic-exposed
MRSA was not altered compared to
that from unexposed bacteria. Of note,
MRSA with poorly crosslinked PGN was
more susceptible to macrophage killing.
The subsequent release of IL-1b after
exposure to either native or antibiotic-
exposed PGN remained dependent on
the phagolysosomal processing of the
PGN within macrophages, on the cyto-
solic inflammasome component NLRP3
(NACHT, LRR, and PYD domains-con-
taining protein 3), and on caspase-1.
NLRP3 can be activated by a variety of
danger signals, and it remains unclear
what phagolysosomal or cytoplasmic
molecules may be involved in upstream
detection of PGN to activate NLRP3.
Intriguingly, macrophages that underwent
NLRP3 inflammasome activation and IL-
1b release in response to PGN from either
S. aureus treated or not treatedwith b-lac-
tams did not enter the inflammatory
pyroptotic cell death pathway that is char-
acteristic of classical inflammasome-acti-
vating signals such as ATP and nigericin.
Pyroptotic cell death after inflamma-
some-mediated activation of caspase-1
involves cellular pore formation that
causes osmotic swelling and ultimately
leads to lysis and the release of cellular
components into the milieu. The release
Figure 1. b-lactam Antibiotics Alter Inflammatory Activity of Staphylococcus aureus
Peptidoglycan
Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), use a number of penicillin-
binding proteins (PBPs) to form a cell wall containing highly crosslinked peptidoglycan (PGN), depicted
here as long golden bricks (top left). b-lactam antibiotics, such asmethicillin, inactivate these native PBPs.
ThemecA gene in MRSA encodes PBP2a, which is resistant to inactivation by b-lactam antibiotics. In this
issue, Mu¨ller et al. (2015) show that, compared to untreated MRSA (left), induction of PBP2a in MRSA
treated with b-lactam antibiotics (right) results in poorly crosslinked PGN, depicted here as shortened
golden bricks (top right). Stimulation of macrophages by PGN from either untreated or antibiotic-treated
MRSA is dependent on phagocytosis (inhibited by cytochalasin D), acidification of the phagolysosome
(inhibited by bafilomycin A1), and phagolysosomal proteases. Both PGN forms equivalently induce
transcription of pro-IL-1b. However, MRSA expressing the poorly crosslinked peptidoglycan are more
effectively killed in the macrophage phagolysosome, and this PGN form more potently activates NLRP3
inflammasome-mediated cleavage by caspase-1 of pro-IL-1b to active IL-1b. This increased secretion of
IL-1b bymacrophages, and presumably other phagocytic cells, leads to enhanced bacterial control in vivo
at the potential expense of increased tissue inflammation.
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independently of each other, since os-
motic protectants prevent lysis but not
cytokine release (Fink and Cookson,
2006). The mechanisms by which PGN-
mediated inflammasome activation andIL-1b release are uncoupled from cell
death remain to be explored.
To investigate whether the effects of
antibiotic-exposed PGN on macrophage
inflammasome activation have implica-
tions for in vivo infection and therapy, LiuCell Host & Microbe 18, Nand colleagues used a mouse model of
cutaneous S. aureus abscess formation,
in which IL-1b plays a critical role in the
neutrophil-mediated protective response
(Miller et al., 2007). Consistent with their
in vitro observations, the authors found
that injection of heat-killed MRSA pre-
treated with b-lactam antibiotics induced
a more robust local IL-1b response in
mice in comparison to injection of non-
treated MRSA. The higher IL-1b levels
correlated with increased abscess size
and weight. Since the use of heat-killed
bacteria precluded bacterial prolifera-
tion or differential toxin production,
the increased abscess size suggested
increased inflammatory cell recruitment.
b-lactam treatment after infection with
live MRSA produced similar results: the
treated animals developed larger lesions
and had increased neutrophil infiltration
despite fewer live bacteria in the abscess,
indicating that the effects were caused by
inflammation rather than bacterial prolif-
eration. This in vivo immunopathology
was shown to be IL-1-dependent using
mice deficient for the IL-1 receptor.
This study highlights the complex inter-
play between host and bacterial factors
that determines the outcome of host-bac-
teria interactions. The relatively nonin-
flammatory nature of normally crosslinked
S. aureus PGN may be viewed as a cloak
from host detection mechanisms. In a
seeming paradox, many secreted toxins
of S. aureus, such as alpha-hemolysin,
Panton-Valentine leukocidin, and LukAB,
induce NLRP3 inflammasome activation
and release of IL-1b, which would be pre-
dicted to lead to increased bacterial clear-
ance but may be counterbalanced by
specific roles of these toxins in virulence
(Vandenesch et al., 2012). The potential
for an excessive host inflammatory
response is evident not only in this study
involving mouse skin abscesses but also
in the neutrophil-mediated inflammation
seen in a rabbit model of pneumonia
(Diep et al., 2010), a site that is likely less
tolerant of inflammation than the skin. In
contrast, as cited by Mu¨ller et al. (2015),
a few studies have suggested potential
benefit to using b-lactam antibiotics
concurrently with MRSA-active antibi-
otics during bloodstream and endocardi-
tis infections, sites where the bactericidal
effects of the inflammatory response may
outweigh its detrimental effects on the
host. The optimal level of inflammationovember 11, 2015 ª2015 Elsevier Inc. 521
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inflammation likely depends on a number
of factors, including site of infection, bac-
terial virulence, and host immune milieu.
The current study by Mu¨ller et al. (2015)
lends mechanistic credence to the possi-
bility that use of antibiotics without con-
ventional antimicrobial activity may still
alter inflammatory responses and affect
clinical outcomes.
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